| Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival D Srinivasan, JT Sims, R Plattner Oncogene 27 (8), 1095-1105, 2008 | 183 | 2008 |
| Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19 JT Sims, V Krishnan, CY Chang, SM Engle, G Casalini, GH Rodgers, ... Journal of Allergy and Clinical Immunology 147 (1), 107-111, 2021 | 162 | 2021 |
| Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1 JT Sims, SS Ganguly, H Bennett, JW Friend, J Tepe, R Plattner PloS one 8 (1), e55509, 2013 | 117 | 2013 |
| c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression SS Ganguly, LS Fiore, JT Sims, JW Friend, D Srinivasan, MA Thacker, ... Oncogene 31 (14), 1804-1816, 2012 | 84 | 2012 |
| Isolation of Salmonella Bacteriophages from Swine Effluent Lagoons MR McLaughlin, MF Balaa, J Sims, R King Journal of environmental quality 35 (2), 522-528, 2006 | 75 | 2006 |
| Anaplasma phagocytophilum APH_0032 is expressed late during infection and localizes to the pathogen-occupied vacuolar membrane B Huang, MJ Troese, D Howe, S Ye, JT Sims, RA Heinzen, DL Borjesson, ... Microbial pathogenesis 49 (5), 273-284, 2010 | 55 | 2010 |
| MTT assays cannot be utilized to study the effects of STI571/Gleevec on the viability of solid tumor cell lines JT Sims, R Plattner Cancer chemotherapy and pharmacology 64, 629-633, 2009 | 55 | 2009 |
| Anaplasma phagocytophilum APH_1387 Is Expressed throughout Bacterial Intracellular Development and Localizes to the Pathogen-Occupied Vacuolar Membrane B Huang, MJ Troese, S Ye, JT Sims, NL Galloway, DL Borjesson, ... Infection and immunity 78 (5), 1864-1873, 2010 | 49 | 2010 |
| Enhanced resistance to tamoxifen by the c-ABL proto-oncogene in breast cancer H Zhao, F Ou-Yang, IF Chen, MF Hou, SSF Yuan, HL Chang, YC Lee, ... Neoplasia 12 (3), 214-IN3, 2010 | 48 | 2010 |
| Virus detection and identification using random multiplex (RT)-PCR with 3'-locked random primers AL Clem, J Sims, S Telang, JW Eaton, J Chesney Virology journal 4, 1-11, 2007 | 45 | 2007 |
| Characterization of a sialic acid‐ and P‐selectin glycoprotein ligand‐1‐independent adhesin activity in the granulocytotropic bacterium Anaplasma phagocytophilum DV Reneer, SA Kearns, T Yago, J Sims, RD Cummings, RP McEver, ... Cellular microbiology 8 (12), 1972-1984, 2006 | 43 | 2006 |
| STI571 sensitizes breast cancer cells to 5-fluorouracil, cisplatin and camptothecin in a cell type-specific manner JT Sims, S Ganguly, LS Fiore, CJ Holler, ES Park, R Plattner Biochemical pharmacology 78 (3), 249-260, 2009 | 29 | 2009 |
| Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus T Dörner, Y Tanaka, ER Dow, AE Koch, M Silk, JAR Terres, JT Sims, ... Annals of the rheumatic diseases 81 (9), 1267-1272, 2022 | 22 | 2022 |
| Insights into adult atopic dermatitis heterogeneity derived from circulating biomarker profiling in patients with moderate‐to‐severe disease JT Sims, CY Chang, RE Higgs, SM Engle, Y Liu, SE Sissons, GH Rodgers, ... Experimental dermatology 30 (11), 1650-1661, 2021 | 19 | 2021 |
| Circulating plasma IL-13 and periostin are dysregulated type 2 inflammatory biomarkers in prurigo nodularis: a cluster analysis V Parthasarathy, K Cravero, J Deng, Z Sun, SM Engle, AN Auxier, N Hahn, ... Frontiers in medicine 9, 1011142, 2022 | 15 | 2022 |
| The blood proteomic signature of prurigo nodularis reveals distinct inflammatory and neuropathic endotypes: a cluster analysis V Parthasarathy, K Cravero, L Xu, J Deng, Z Sun, SM Engle, JT Sims, ... Journal of the American Academy of Dermatology 88 (5), 1101-1109, 2023 | 10 | 2023 |
| Predictive biomarker modeling of pediatric atopic dermatitis severity based on longitudinal serum collection S Engle, CY Chang, B Ulrich, A Satterwhite, T Hayes, K Robling, ... Clinical and experimental immunology, 2021 | 9* | 2021 |
| Interleukin‐33 antibody failed to demonstrate benefit in a phase II, double‐blind, randomized, placebo‐controlled study in adult patients with moderate‐to‐severe atopic dermatitis V Laquer, V Parra, JP Lacour, H Takahashi, J Knorr, AJ Okragly, ... British Journal of Dermatology 187 (4), 599-602, 2022 | 8 | 2022 |
| Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing … JT Sims, J Poorbaugh, CY Chang, TR Holzer, L Zhang, SM Engle, ... Journal of Translational Medicine 20 (1), 134, 2022 | 7 | 2022 |
| Transcriptomic analysis of healthy and atopic dermatitis samples reveals the role of IL-37 in human skin J Zhou, DC Gemperline, MJ Turner, J Oldach, J Molignano, JT Sims, ... Immunohorizons 5 (10), 830-843, 2021 | 7 | 2021 |
